orbofiban has been researched along with Diabetic Angiopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braunwald, E; Buros, J; Cannon, CP; Gibson, CM; Kirtane, AJ; McCabe, CH; Morrow, DA; Ray, KK; Rifai, N | 1 |
1 trial(s) available for orbofiban and Diabetic Angiopathies
Article | Year |
---|---|
Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18.
Topics: Aged; Alanine; Biomarkers; Blood Glucose; C-Reactive Protein; Chemokine CCL2; Diabetic Angiopathies; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Middle Aged; Myocardial Ischemia; Myocarditis; Pyrrolidines; von Willebrand Factor | 2007 |